Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial Fibrillation
NCT ID: NCT02433366
Last Updated: 2016-09-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1213 participants
OBSERVATIONAL
2015-01-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Decision Support for Stroke Prevention in Atrial Fibrillation
NCT02635685
Post-Marketing Surveillance of Prazaxa® on the Long-term Use in Patients With Nonvalvular Atrial Fibrillation
NCT01491178
Computerized Decision Support to Prevent Stroke in Atrial Fibrillation
NCT06355986
Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter
NCT02339493
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
NCT05293080
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
No interventions assigned to this group
Physicians
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with atrial fibrillation treated with Pradaxa®
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boehringer Ingelheim
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Boehringer Ingelheim
Role: STUDY_CHAIR
Boehringer Ingelheim
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boehringer Ingelheim Investigational Site 81
Dobrich, , Bulgaria
Boehringer Ingelheim Investigational Site 84
Gabrovo, , Bulgaria
Boehringer Ingelheim Investigational Site 79
Montana, , Bulgaria
Boehringer Ingelheim Investigational Site 85
Plovdiv, , Bulgaria
Boehringer Ingelheim Investigational Site 80
Shumen, , Bulgaria
Boehringer Ingelheim Investigational Site 86
Sliven, , Bulgaria
Boehringer Ingelheim Investigational Site 87
Sofia, , Bulgaria
Boehringer Ingelheim Investigational Site 88
Stara Zagora, , Bulgaria
Boehringer Ingelheim Investigational Site 82
Varna, , Bulgaria
Boehringer Ingelheim Investigational Site 83
Veliko Tarnovo, , Bulgaria
Boehringer Ingelheim Investigational Site 92
?eská Lípa, , Czechia
Boehringer Ingelheim Investigational Site 93
?eské Bud?jovice, , Czechia
Boehringer Ingelheim Investigational Site 94
?eský Krumlov, , Czechia
Boehringer Ingelheim Investigational Site 90
B?eclav, , Czechia
Boehringer Ingelheim Investigational Site 89
Benesov U Prahy, , Czechia
Boehringer Ingelheim Investigational Site 91
Brno, , Czechia
Boehringer Ingelheim Investigational Site 95
Chomutov, , Czechia
Boehringer Ingelheim Investigational Site 96
Domažlice, , Czechia
Boehringer Ingelheim Investigational Site 97
Haví?ov, , Czechia
Boehringer Ingelheim Investigational Site 98
Havlí?k?v Brod, , Czechia
Boehringer Ingelheim Investigational Site 99
Ho?ovice, , Czechia
Boehringer Ingelheim Investigational Site 100
Hradec Králové, , Czechia
Boehringer Ingelheim Investigational Site 101
Ivan?ice, , Czechia
Boehringer Ingelheim Investigational Site 102
Krom??íz, , Czechia
Boehringer Ingelheim Investigational Site 103
Kyjov, , Czechia
Boehringer Ingelheim Investigational Site 104
Liberec, , Czechia
Boehringer Ingelheim Investigational Site 105
Louny, , Czechia
Boehringer Ingelheim Investigational Site 106
Most, , Czechia
Boehringer Ingelheim Investigational Site 107
Nový Bor, , Czechia
Boehringer Ingelheim Investigational Site 108
Odry, , Czechia
Boehringer Ingelheim Investigational Site 109
Olomouc, , Czechia
Boehringer Ingelheim Investigational Site 110
Pardubice, , Czechia
Boehringer Ingelheim Investigational Site 111
Plze?, , Czechia
Boehringer Ingelheim Investigational Site 112
Prague, , Czechia
Boehringer Ingelheim Investigational Site 113
Sternberk, , Czechia
Boehringer Ingelheim Investigational Site 114
Tábor, , Czechia
Boehringer Ingelheim Investigational Site 115
Tehovec, , Czechia
Boehringer Ingelheim Investigational Site 116
Teplice, , Czechia
Boehringer Ingelheim Investigational Site 117
Valasské Mezi?í?í, , Czechia
Boehringer Ingelheim Investigational Site 69
Copenhagen, , Denmark
Boehringer Ingelheim Investigational Site 25
Ambleuteuse, , France
Boehringer Ingelheim Investigational Site 68
Ardres, , France
Boehringer Ingelheim Investigational Site 26
Arnac-Pompadour, , France
Boehringer Ingelheim Investigational Site 27
Audincourt, , France
Boehringer Ingelheim Investigational Site 28
Bart, , France
Boehringer Ingelheim Investigational Site 29
Besançon, , France
Boehringer Ingelheim Investigational Site 30
Buissière Galant, , France
Boehringer Ingelheim Investigational Site 31
Charbrignac, , France
Boehringer Ingelheim Investigational Site 32
Châlus, , France
Boehringer Ingelheim Investigational Site 33
Coussac-Bonneval, , France
Boehringer Ingelheim Investigational Site 34
Décines-Charpieu, , France
Boehringer Ingelheim Investigational Site 35
Eckwersheim, , France
Boehringer Ingelheim Investigational Site 36
Geneuille, , France
Boehringer Ingelheim Investigational Site 37
Glandon, , France
Boehringer Ingelheim Investigational Site 65
Gruson, , France
Boehringer Ingelheim Investigational Site 38
Halluin, , France
Boehringer Ingelheim Investigational Site 39
Lanouaille, , France
Boehringer Ingelheim Investigational Site 67
Le Catelet, , France
Boehringer Ingelheim Investigational Site 40
Le Haillan, , France
Boehringer Ingelheim Investigational Site 41
Lille, , France
Boehringer Ingelheim Investigational Site 42
Limoges, , France
Boehringer Ingelheim Investigational Site 43
Lomme, , France
Boehringer Ingelheim Investigational Site 44
Lyon, , France
Boehringer Ingelheim Investigational Site 45
Marseille, , France
Boehringer Ingelheim Investigational Site 46
Mérignac, , France
Boehringer Ingelheim Investigational Site 47
Nexon, , France
Boehringer Ingelheim Investigational Site 48
Noaillan, , France
Boehringer Ingelheim Investigational Site 24
Paris, , France
Boehringer Ingelheim Investigational Site 52
Saint Saud Lacousserie, , France
Boehringer Ingelheim Investigational Site 55
Saint-Hilaire-les-Places, , France
Boehringer Ingelheim Investigational Site 50
Saint-Martial-d'Albarède, , France
Boehringer Ingelheim Investigational Site 51
Saint-Martin-Sepert, , France
Boehringer Ingelheim Investigational Site 53
Saint-Sornin-Lavolps, , France
Boehringer Ingelheim Investigational Site 54
Saint-Yrieix-la-Perche, , France
Boehringer Ingelheim Investigational Site 56
Schiltigheim, , France
Boehringer Ingelheim Investigational Site 57
Sochaux, , France
Boehringer Ingelheim Investigational Site 58
Strasbourg, , France
Boehringer Ingelheim Investigational Site 59
Talence, , France
Boehringer Ingelheim Investigational Site 60
Thiviers, , France
Boehringer Ingelheim Investigational Site 66
Tourcoing, , France
Boehringer Ingelheim Investigational Site 61
Tourmignies, , France
Boehringer Ingelheim Investigational Site 49
Val Pompadour, , France
Boehringer Ingelheim Investigational Site 62
Villenave-d'Ornon, , France
Boehringer Ingelheim Investigational Site 63
Voujeaucourt, , France
Boehringer Ingelheim Investigational Site 64
Weyersheim, , France
Boehringer Ingelheim Investigational Site 9
Berlin, , Germany
Boehringer Ingelheim Investigational Site 3
Bremen, , Germany
Boehringer Ingelheim Investigational Site 10
Chemnitz, , Germany
Boehringer Ingelheim Investigational Site 5
Düsseldorf, , Germany
Boehringer Ingelheim Investigational Site 6
Essen, , Germany
Boehringer Ingelheim Investigational Site 1
Frankfurt, , Germany
Boehringer Ingelheim Investigational Site 8
Hanover, , Germany
Boehringer Ingelheim Investigational Site 14
Heidelberg, , Germany
Boehringer Ingelheim Investigational Site 11
Leipzig, , Germany
Boehringer Ingelheim Investigational Site 2
Mannheim, , Germany
Boehringer Ingelheim Investigational Site 7
Marburg, , Germany
Boehringer Ingelheim Investigational Site 13
München, , Germany
Boehringer Ingelheim Investigational Site 4
Nuremberg, , Germany
Boehringer Ingelheim Investigational Site 12
Rostock, , Germany
Boehringer Ingelheim Investigational Site 122
Banská Bystrica, , Slovakia
Boehringer Ingelheim Investigational Site 127
Bardejov, , Slovakia
Boehringer Ingelheim Investigational Site 152
Bratislava, , Slovakia
Boehringer Ingelheim Investigational Site 146
Čierna nad Tisou, , Slovakia
Boehringer Ingelheim Investigational Site 149
Čierne Kľačany, , Slovakia
Boehringer Ingelheim Investigational Site 154
Čierny Brod, , Slovakia
Boehringer Ingelheim Investigational Site 139
Dolné Kočkovce, , Slovakia
Boehringer Ingelheim Investigational Site 141
Horný Vadičov, , Slovakia
Boehringer Ingelheim Investigational Site 137
Ivanka pri Dunaji, , Slovakia
Boehringer Ingelheim Investigational Site 140
Jelka, , Slovakia
Boehringer Ingelheim Investigational Site 159
Kokava nad Rimavicou, , Slovakia
Boehringer Ingelheim Investigational Site 125
Košice, , Slovakia
Boehringer Ingelheim Investigational Site 158
Košťany nad Turcom, , Slovakia
Boehringer Ingelheim Investigational Site 160
Krásno nad Kysucou, , Slovakia
Boehringer Ingelheim Investigational Site 134
Lalinok, , Slovakia
Boehringer Ingelheim Investigational Site 120
Lastovce, , Slovakia
Boehringer Ingelheim Investigational Site 155
Liptovský Hrádok, , Slovakia
Boehringer Ingelheim Investigational Site 145
Lučenec, , Slovakia
Boehringer Ingelheim Investigational Site 144
Nitra, , Slovakia
Boehringer Ingelheim Investigational Site 119
Nové Mesto nad Váhom, , Slovakia
Boehringer Ingelheim Investigational Site 150
Nové Zámky, , Slovakia
Boehringer Ingelheim Investigational Site 124
Odorín, , Slovakia
Boehringer Ingelheim Investigational Site 142
Oščadnica, , Slovakia
Boehringer Ingelheim Investigational Site 157
Poprad, , Slovakia
Boehringer Ingelheim Investigational Site 128
Považská Bystrica, , Slovakia
Boehringer Ingelheim Investigational Site 132
Považský Chlmec, , Slovakia
Boehringer Ingelheim Investigational Site 118
Prešov, , Slovakia
Boehringer Ingelheim Investigational Site 138
Púchov, , Slovakia
Boehringer Ingelheim Investigational Site 143
Radola, , Slovakia
Boehringer Ingelheim Investigational Site 153
Rešov, , Slovakia
Boehringer Ingelheim Investigational Site 156
Revúca, , Slovakia
Boehringer Ingelheim Investigational Site 147
Rožkovany, , Slovakia
Boehringer Ingelheim Investigational Site 131
Rudinka, , Slovakia
Boehringer Ingelheim Investigational Site 126
Sabinov, , Slovakia
Boehringer Ingelheim Investigational Site 161
Skalité, , Slovakia
Boehringer Ingelheim Investigational Site 123
Spišská Nová Ves, , Slovakia
Boehringer Ingelheim Investigational Site 130
Stráňavy, , Slovakia
Boehringer Ingelheim Investigational Site 121
Trebišov, , Slovakia
Boehringer Ingelheim Investigational Site 151
Trnava, , Slovakia
Boehringer Ingelheim Investigational Site 129
Trnové, , Slovakia
Boehringer Ingelheim Investigational Site 135
Valasska Bela, , Slovakia
Boehringer Ingelheim Investigational Site 148
Vráble, , Slovakia
Boehringer Ingelheim Investigational Site 136
Zvolen, , Slovakia
Boehringer Ingelheim Investigational Site 133
Žilina, , Slovakia
Boehringer Ingelheim Investigational Site 23
Baleares, , Spain
Boehringer Ingelheim Investigational Site 22
Barcelona, , Spain
Boehringer Ingelheim Investigational Site 15
Ciudad Real, , Spain
Boehringer Ingelheim Investigational Site 16
Galicia, , Spain
Boehringer Ingelheim Investigational Site 17
Madrid, , Spain
Boehringer Ingelheim Investigational Site 18
Murcia, , Spain
Boehringer Ingelheim Investigational Site 19
Seville, , Spain
Boehringer Ingelheim Investigational Site 20
Valencia, , Spain
Boehringer Ingelheim Investigational Site 21
Zaragoza, , Spain
Boehringer Ingelheim Investigational Site 71
Brighton, , United Kingdom
Boehringer Ingelheim Investigational Site 76
Cheadle, , United Kingdom
Boehringer Ingelheim Investigational Site 78
Essex, , United Kingdom
Boehringer Ingelheim Investigational Site 70
London, , United Kingdom
Boehringer Ingelheim Investigational Site 77
Manchester, , United Kingdom
Boehringer Ingelheim Investigational Site 74
Middlesex, , United Kingdom
Boehringer Ingelheim Investigational Site 73
Romford, , United Kingdom
Boehringer Ingelheim Investigational Site 75
Stockport, , United Kingdom
Boehringer Ingelheim Investigational Site 72
Surrey, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1160.149
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.